Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses.
Aluminum hydroxide salts (alum) have been added to inactivated vaccines as safe and effective adjuvants to increase the effectiveness of vaccination. However, the exact cell types and immunological factors that initiate mucosal immune responses to alum adjuvants are unclear. In this study, the mecha...
Guardado en:
Autores principales: | Eita Sasaki, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, Isao Hamaguchi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15c234d22ce84c1fafd85299b4e18f64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of injection buffer volume to perform bronchoalveolar lavage fluid collection for isolating alveolar macrophages to investigate fine particle-induced IL-1α secretion
por: Eita Sasaki, et al.
Publicado: (2021) -
Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy
por: Qiuting Chen, et al.
Publicado: (2021) -
Neutrophil swarming and extracellular trap formation play a significant role in Alum adjuvant activity
por: J. Stephen, et al.
Publicado: (2017) -
An Established Th2-Oriented Response to an Alum-Adjuvanted SARS-CoV-2 Subunit Vaccine Is Not Reversible by Sequential Immunization with Nucleic Acid-Adjuvanted Th1-Oriented Subunit Vaccines
por: Han Cao, et al.
Publicado: (2021) -
Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
por: Yinyan Yin, et al.
Publicado: (2021)